Evidence map›Paper›PMID 33976459›Full record

ArticleReumatologia2021

Social media platforms: a primer for researchers.

Olena Zimba, Armen Yuri Gasparyan

Abstract read
In one paragraph

Article in Reumatologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Social media landscape of rheumatology journals.Rheumatology international · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Olena ZimbaDepartment of Internal Medicine No. 2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Armen Yuri GasparyanDepartments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Social media platforms play an increasingly important role in research, education, and clinical practice. As an inseparable part of open science, these platforms may increase the visibility of research outputs and facilitate scholarly networking. The editors who ethically moderate Twitter, Facebook, and other popular social media accounts for their journals may engage influential authors in the post-publication communication and expand societal implications of their publications. Several social media aggregators track and generate alternative metrics which can be used by researchers for visualizing trending articles in their fields. More and more publishers showcase their achievements by displaying such metrics along with traditional citations. The Scopus database also tracks both metrics to offer a comprehensive coverage of the indexed articles' impact. Understanding the advantages and limitations of various social media channels is essential for actively contributing to the post-publication communication, particularly in research-intensive fields such as rheumatology.

Indexed as

periodicals as topicpublication ethicsrheumatologysocial media

Identifiers

PMID33976459
PMCPMC8103414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.